Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nature Neuroscience|October 31, 2002
NMDA receptor pathways as drug targetsJohn A Kemp, Ruth M McKernan
Pharmacological Research|August 21, 2025
All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressantsFlorian Freudenberg, Christine Reif-Leonhard, Gerard R Dawson, et al.
British Journal of Pharmacology|September 27, 2005
Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513Luanda J Pym, Susan M Cook, Thomas Rosahl, et al.
Neuropharmacology|July 6, 2005
In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708John R Atack, Luanda Alder, Susan M Cook, et al.
European Journal of Pharmacology|September 12, 2006
The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediatedJohn R Atack, Peter J Bayley, Stephen R Fletcher, et al.
Neuropharmacology|October 19, 2006
L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptorsJohn R Atack, Peter J Bayley, Guy R Seabrook, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
Rat pharmacokinetics and pharmacodynamics of a sustained release formulation of the GABAA alpha5-selective compound L-655,708John R Atack, Andy Pike, Ashley Clarke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 5, 2026
Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals ProgrammeRuth M McKernan, James B Rowe, Sally John, et al.
British Journal of Pharmacology|January 19, 2005
Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptorsJohn R Atack, Peter H Hutson, Neil Collinson, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Pyrazolopyridinones as functionally selective GABAA ligandsWesley P Blackaby, John R Atack, Frances Bromidge, et al.
Pageof 3